Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Agenus Inc. - Common Stock
(NQ:
AGEN
)
3.160
-0.420 (-11.73%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 18, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Agenus Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Agenus Announces New Data from Expanded MSS Metastatic Colorectal Cancer Cohort to be Presented at ESMO GI 2025
May 15, 2025
From
Agenus Inc.
Via
Business Wire
12 Health Care Stocks Moving In Monday's Intraday Session
↗
May 12, 2025
Via
Benzinga
Agenus Reports Q1 2025 Financial Results and Key Business Updates
May 12, 2025
From
Agenus Inc.
Via
Business Wire
Earnings Scheduled For May 12, 2025
↗
May 12, 2025
Via
Benzinga
Agenus's Earnings: A Preview
↗
May 09, 2025
Via
Benzinga
Earnings Scheduled For November 12, 2024
↗
November 12, 2024
Via
Benzinga
Renowned GI Oncology Leader Dr. Richard Goldberg Joins Agenus as Chief Development Officer
May 12, 2025
From
Agenus Inc.
Via
Business Wire
Agenus to Provide Corporate Update and First Quarter 2025 Financial Report
April 29, 2025
From
Agenus Inc.
Via
Business Wire
Agenus’ BOT/BAL Neoadjuvant Pan-Cancer Data from the NEOASIS Study Presented in an Oral Session at AACR
April 28, 2025
From
Agenus Inc.
Via
Business Wire
Agenus’ BOT/BAL Data in Pretreated Liver Cancer Presented at AACR 2025
April 25, 2025
From
Agenus Inc.
Via
Business Wire
Agenus Announces Botensilimab and Balstilimab Presentations at ASCO 2025
April 23, 2025
From
Agenus Inc.
Via
Business Wire
Here are the top movers in Tuesday's session.
↗
April 22, 2025
Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session.
Via
Chartmill
Agenus to Present New BOT/BAL Data in Two Presentations at AACR 2025
March 25, 2025
From
Agenus Inc.
Via
Business Wire
Agenus Unveils Colorectal Cancer Survey Findings, Highlighting the Urgent Need for Treatment Innovation
March 19, 2025
From
Agenus Inc.
Via
Business Wire
Agenus (AGEN) Q4 2024 Earnings Call Transcript
↗
March 11, 2025
AGEN earnings call for the period ending December 31, 2024.
Via
The Motley Fool
Topics
Earnings
Agenus Reports Q4 and Year-End 2024 Results; Strategic Operational Improvements and Significant Cost Reductions Enhance Sustainability of Promising BOT/BAL Program
March 11, 2025
From
Agenus Inc.
Via
Business Wire
Earnings Scheduled For March 11, 2025
↗
March 11, 2025
Via
Benzinga
Agenus Reports Impact of Key Immuno-Oncology Data Presented at Leading Medical Conferences and Peer-Reviewed Publications
February 26, 2025
From
Agenus Inc.
Via
Business Wire
Agenus to Participate in B. Riley Securities Precision Oncology & Radiopharma Investor Conference
February 25, 2025
From
Agenus Inc.
Via
Business Wire
Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report
February 25, 2025
From
Agenus Inc.
Via
Business Wire
Agenus Presents New Botensilimab/Balstilimab Data in Gastric Cancer at AACR IO Annual Meeting
February 24, 2025
From
Agenus Inc.
Via
Business Wire
CORRECTING and REPLACING Agenus’ BOT/BAL Selected for Two Presentations at Upcoming AACR IO Annual Meeting
February 23, 2025
From
Agenus Inc.
Via
Business Wire
Agenus Announces Publication in the Journal of Clinical Oncology Highlighting Data from Botensilimab Plus Balstilimab in Relapsed/Refractory Metastatic Sarcomas
January 29, 2025
From
Agenus Inc.
Via
Business Wire
Agenus Presents Data at ASCO GI Demonstrating Impact of BOT/BAL in Colorectal Cancer Across Neoadjuvant and Advanced Disease
January 22, 2025
From
Agenus Inc.
Via
Business Wire
Agenus Announces Five Presentations at ASCO GI Highlighting BOT/BAL Activity Across Colorectal and Gastric Cancers
December 18, 2024
From
Agenus Inc.
Via
Business Wire
Agenus Announces Strategic Realignment to Focus on Core Programs and Significantly Reduce Costs
December 05, 2024
From
Agenus Inc.
Via
Business Wire
Agenus Gets $22M Mortgage, Plans Strategic Realignment To Focus On Colorectal Cancer Drug Development
↗
November 27, 2024
Agenus secures a $22M mortgage and announces a strategic realignment to focus on botensilimab/balstilimab in MSS colorectal cancer.
Via
Benzinga
Agenus Secures $22 Million Mortgage and Announces Strategic Operational Realignment
November 27, 2024
From
Agenus Inc.
Via
Business Wire
Agenus (AGEN) Q3 2024 Earnings Call Transcript
↗
November 12, 2024
AGEN earnings call for the period ending September 30, 2024.
Via
The Motley Fool
Topics
Earnings
Agenus Reports Third Quarter 2024 Financial Results and Strategic Advancements in BOT/BAL Development
November 12, 2024
From
Agenus Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
